|
ALT levels (U/L)
|
Hypertensive, n (%)
|
Age-Sex-adjusted OR (95% CI)
|
Multi-adjusted OR (95% CI)*
|
|---|
|
Group I
| | | |
|
0–40
|
5,753,021 (30.86)
|
1
|
1
|
|
40.01–
|
1,091,213 (44.29)
|
1.37 (1.36,1.37)
|
1.17 (1.16,1.17)
|
|
Group II
| | | |
|
0–20
|
2,935,226 (27.37)
|
1
|
1
|
|
20.01–40
|
2,817,795 (35.60)
|
1.16 (1.16,1.16)
|
1.09 (1.08,1.09)
|
|
40.01–60
|
605,968 (43.36)
|
1.42 (1.41,1.43)
|
1.21 (1.20,1.21)
|
|
60.01–80
|
239,252 (44.90)
|
1.51 (1.50,1.52)
|
1.22 (1.22,1.23)
|
|
80.01–
|
245,993 (46.11)
|
1.60 (1.59,1.61)
|
1.25 (1.25,1.26)
|
|
P for trend†
| |
< 0.001
|
< 0.001
|
- ALT: alanine aminotransferase; OR: odds ratios; CI: confidence interval;
- *Adjusted for age, sex, ethnicity, area, education, body mass index, average salt consumption, history of diabetes, overall pressure and hepatitis B surface antigen status;
- †P for trend were calculated by set categorized ALT levels as a continuous variable
